CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mycovia Pharmaceuticals, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mycovia Pharmaceuticals, Inc.
4505 Emperor Blvd Ste 300
Phone: (919) 467-8539p:919 467-8539 Durham, NC  27703  United States Fax: (302) 655-5049f:302 655-5049
Viamet Pharmaceuticals Holdings LLC filed a Registration Withdrawal Request of its Form S-1 (File No. 333-197143) with the SEC on 10/20/2014. The Registration Statement was filed in connection with the proposed public offering by the Company of its common stock, which the Company has determined not to pursue at this time.
Business Summary
Mycovia Pharmaceuticals, formerly Viamet Pharmaceuticals Holdings, LLC, discovers and develops novel therapeutic agents that target metalloenzymes or interfere with the cell's ability to effectively utilize critical metal ions such as zinc and iron.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/201612/31/2015YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board RobertIngram
President, Chief Executive Officer, Director Robert J.Schotzinger
Director JeffreyEdwards
Director AdrianHowd
Director Andrewvon Eschenbach

Business Names
Business Name
Viamet Pharmaceuticals, Inc.
VPS-1, Inc.
VPS-2, Inc.
VPS-3, Inc.

General Information
Number of Employees: 29 (As of 3/31/2016)
Outstanding Shares: 25,962,524 (As of 5/11/2016)
Shareholders: 55
Stock Exchange: NASD
Federal Tax Id: 454059526
Fax Number: (302) 655-5049
Email Address: info@mycovia.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023